Targeting PDE3B Protects Gut Barrier and Curbs Liver Fibrosis in Mice
Genetic deletion and pharmacological inhibition of phosphodiesterase 3B protected intestinal barrier integrity and suppressed hepatic inflammation and fibrosis in mouse ...
Genetic deletion and pharmacological inhibition of phosphodiesterase 3B protected intestinal barrier integrity and suppressed hepatic inflammation and fibrosis in mouse ...
Researchers have identified FADS1 as a candidate shared biomarker linking metabolic dysfunction-associated steatohepatitis to early-onset colorectal cancer through machine learning ...
A comprehensive scientific review details how oxidative stress drives metabolic dysfunction-associated steatotic liver disease progression and explains why standalone antioxidant ...
A computational transcriptomic analysis demonstrates that sex differences in metabolic liver disease are defined by pathway architecture and continuous severity ...
Two major international studies from the LITMUS consortium have established comprehensive accuracy benchmarks for non-invasive blood and imaging tests to ...
Loss of the ATM kinase drives mitochondrial hypermetabolism and bioenergetic failure, worsening liver injury and fibrosis in metabolic dysfunction-associated steatotic ...
A study of postmarketing FAERS data found elevated liver and biliary reporting signals for resmetirom that partly attenuated against active ...
A systematic review and meta-analysis found significantly higher circulating lipocalin-2 levels in patients with metabolic dysfunction-associated steatotic liver disease compared ...
A newly published review presents a clinical stratification framework that connects MASLD subtypes, risk profiling, and diagnostic tools to personalized ...
A two-cohort human transcriptomic study demonstrates that elevated MDK expression and suppressed fatty-acid beta-oxidation form a reciprocal transcriptional signature in ...
An 11-protein signature from circulating extracellular vesicles, validated in an independent cohort, was associated with advanced fibrosis in MASH and ...
An integrative RNA sequencing and machine learning study identified a seven-gene signature and key liver cell subpopulations associated with advanced ...
Researchers have developed a k-mer-based estimator that accurately measures substitution rates in highly repetitive genomic sequences where existing tools like ...
A new review builds an evidence-tiered framework for predicting GLP-1 therapy response in fatty liver disease using host genotype and ...
A spatial transcriptomics study of 16 MASH patients and eight controls maps compartment-specific CYP450 suppression, immune activation, and disrupted cell-cell ...
A preclinical mouse study found that Gudan Wan reduced liver injury, inflammation and fibrosis while altering autophagy- and apoptosis-related proteins, ...
A review finds that microbial metabolites may influence variable responses to MASH therapies, but direct clinical evidence linking gut microbial ...
A new review proposes that lipid metabolism plays fundamentally different roles at each stage of fatty liver disease progression to ...
A Duke-NUS pre-clinical study has created the first diet-induced mouse model of lean MASH, showing that excess dietary salt can ...
A phase-2 randomized trial shows intermittent dasatinib plus quercetin significantly improved liver fibrosis and resolved MASH in nearly half of ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.